EUVIMEDEUVIMED entdecken
Crossref

Discovering the natural source-derived antihypertensive compounds aspiring current therapeutic targets by computer-based drug design

Nail Besli, Nilufer Ercin, Rabia Kalkan-Cakmak, Bahar Sarikamis-Johnson, Merve Beker, Ulkan Celik

Biochemical and Biophysical Research Communications · 2025

DOI: 10.1016/j.bbrc.2025.151685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von Nail Besli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Hamidiye School of Medicine, University of Health Sciences, Istanbul, Türkiye. Electronic address: beslinail@gmail.com. Hauptthemen laut MEDLINE: Antihypertensive Agents, Drug Design, Hypertension, Biological Products. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension, a primary global health concern, heightens the risk of heart, brain, and kidney diseases and contributes to premature mortality. The present paper thoroughly explores the potential therapeutic use of natural compounds, drawing on Avicenna's ancient medical philosophy to highlight the role of bodily humor imbalances and lifestyle factors in hypertension. A key aspect of our study is using a computer-aided drug design (CADD) approach, which we employ to identify novel antihypertensive bio-compounds, focusing on current therapeutic targets, including angiotensin I-converting enzyme, angiotensin II receptor, and calcium channel. Comprehensive molecular docking and dynamic simulations were employed to evaluate the binding interactions and affinities of these compounds with key hypertension-related proteins. Using Molecular Mechanics Poisson-Boltzmann Surface Area (MM-PBSA) for binding free energy calculations and ADMET analysis to enhance the precision of our findings, we identified standout candidates from the AVICENNA database, including FDB014401, FDB014715, and FDB014560. These compounds exhibited outstanding docking scores, ranging from -9.60 to -11.60 kcal/mol across three targets, highlighting their potential to act as potent inhibitors of the intended proteins. Molecular dynamics simulations reveal that these bio-compounds maintain stable interactions with target proteins over 100 ns, with no significant conformational alterations, underscoring their promise as viable antihypertensive agents. Due to our study's thoroughness, these findings provide a solid foundation for forthcoming pre-clinic and empiric studies, and the successful use of CADD in our research instills confidence in its potential to discover novel, naturally derived antihypertensive therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsDrug DesignHypertensionBiological ProductsComputer-Aided DesignHumansMolecular Docking SimulationMolecular Dynamics SimulationPeptidyl-Dipeptidase AAngiotensin-Converting Enzyme Inhibitors

Stichwörter der Autor:innen

Ang II receptorAngiotensin-converting enzymeAntihypertensive compoundsCalcium channelComputer-aided drug design

Substanzen

Antihypertensive AgentsBiological ProductsPeptidyl-Dipeptidase AAngiotensin-Converting Enzyme Inhibitors

Autor:innen und Institutionen

  • Department of Medical Biology, Hamidiye School of Medicine, University of Health Sciences, Istanbul, Türkiye. Electronic address: beslinail@gmail.com.
  • Department of Medical Biology, Hamidiye School of Medicine, University of Health Sciences, Istanbul, Türkiye. Electronic address: nlfrbilgic@gmail.com.
  • Department of Medical Biology, Hamidiye School of Medicine, University of Health Sciences, Istanbul, Türkiye. Electronic address: rabiaklkn@gmail.com.
  • Department of Medical Biology, Hamidiye School of Medicine, University of Health Sciences, Istanbul, Türkiye. Electronic address: baharsarikamis@gmail.com.
  • Department of Medical Biology, Hamidiye International School of Medicine, University of Health Sciences, Istanbul, Türkiye. Electronic address: karakasmrv@gmail.com.
  • Department of Medical Biology, Hamidiye School of Medicine, University of Health Sciences, Istanbul, Türkiye; Department of Medical Biology, Institute of Health Sciences, University of Health Sciences, Istanbul, Türkiye.

Zitieren

APA

Besli, N., Ercin, N., Kalkan-Cakmak, R., Sarikamis-Johnson, B., Beker, M., & Celik, U. (2025). Discovering the natural source-derived antihypertensive compounds aspiring current therapeutic targets by computer-based drug design. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.151685

Vancouver

Besli N, Ercin N, Kalkan-Cakmak R, Sarikamis-Johnson B, Beker M, Celik U. Discovering the natural source-derived antihypertensive compounds aspiring current therapeutic targets by computer-based drug design. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.151685

BibTeX
@article{Besli2025,
  author = {Besli, Nail and Ercin, Nilufer and Kalkan-Cakmak, Rabia and Sarikamis-Johnson, Bahar and Beker, Merve and Celik, Ulkan},
  title = {Discovering the natural source-derived antihypertensive compounds aspiring current therapeutic targets by computer-based drug design},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2025},
  doi = {10.1016/j.bbrc.2025.151685}
}
Kostenlos starten →